Laboratorios Farmaceuticos Rovi Overview

  • Founded
  • 1946

Founded
  • Status
  • Public

  • Employees
  • 1,852

Employees
  • Stock Symbol
  • ROVI

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $40.80

  • (As of Tuesday Closing)

Laboratorios Farmaceuticos Rovi General Information

Description

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments.

Contact Information

Website
www.rovi.es
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
MAD
Primary Office
  • Calle José Isbert, 2
  • 28223 Madrid
  • Spain
+34 910 00 00 00

Laboratorios Farmaceuticos Rovi Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Laboratorios Farmaceuticos Rovi Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$40.80 $40.23 $39.49 - $84.85 $2.09B 51.3M 103K $3.76

Laboratorios Farmaceuticos Rovi Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 3,255,990 4,498,597 2,540,827 1,515,660
Revenue 832,246 766,930 478,719 426,859
EBITDA 277,800 241,890 105,985 67,942
Net Income 205,716 180,983 69,600 43,964
Total Assets 826,864 829,551 706,541 572,644
Total Debt 76,390 82,816 90,425 94,852
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Laboratorios Farmaceuticos Rovi Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laboratorios Farmaceuticos Rovi‘s full profile, request access.

Request a free trial

Laboratorios Farmaceuticos Rovi Patents

Laboratorios Farmaceuticos Rovi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2792298-R2 Procedure for obtaining low molecular weight heparins and low molecular weight heparins obtained by the same Active 27-Apr-2020
ES-2792298-A2 Procedure for obtaining low molecular weight heparins and low molecular weight heparins obtained by the same (machine-translation by google translate, not legally binding) Active 27-Apr-2020
ES-2792298-B2 Procedure for obtaining low molecular weight heparins and low molecular weight heparins obtained by the same Active 27-Apr-2020
ES-2847281-A1 Low and very low molecular weight heparins for the treatment of deep venous thrombosis (machine-translation by google translate, not legally binding) Active 31-Jan-2020 0000000000
CA-3134458-A1 Method for obtaining low-molecular-weight heparins by means of tangential flow filtration Pending 26-Apr-2019 C08B37/0075
To view Laboratorios Farmaceuticos Rovi’s complete patent history, request access »

Laboratorios Farmaceuticos Rovi Executive Team (6)

Name Title Board Seat Contact Info
Juan Encina Chief Executive Officer & Board Member
Javier Encina Chief Financial Officer, Finance & Deputy Chairman
Marta Martínez Head, Investor Relations
Miguel Román Manager-International & Business Development
Ivan Encina Deputy Chairman & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Laboratorios Farmaceuticos Rovi Board Members (4)

Name Representing Role Since
0000 000000 Laboratorios Farmaceuticos Rovi Deputy Chairman & Board Member 000 0000
0000 00000000 00 0000000 000000-0000000 Laboratorios Farmaceuticos Rovi Board Member 000 0000
0000 000000 Laboratorios Farmaceuticos Rovi Chief Executive Officer & Board Member 000 0000
00000 000000 000000 Self Board Member 000 0000
To view Laboratorios Farmaceuticos Rovi’s complete board members history, request access »

Laboratorios Farmaceuticos Rovi Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Laboratorios Farmaceuticos Rovi Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Laboratorios Farmaceuticos Rovi‘s full profile, request access.

Request a free trial

Laboratorios Farmaceuticos Rovi Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 (00000000 15-Feb-2019 000000000 000.00 Buildings and Property 0000 0000
To view Laboratorios Farmaceuticos Rovi’s complete investments history, request access »